The Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisation for Mounjaro, a new medicine, to treat type 2 diabetes in adults. This authorization comes after promising results from clinical trials that showed Mounjaro remarkably decreases blood sugar levels in patients. Mounjaro functions as a once-weekly injectio